Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2
Source: SeekingAlpha
2026-03-04 18:32:57 ET
More on Verastem
- Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript
- Verastem: Downgrading To Buy Based On RAMP-203 Setback In Targeting KRAS G12C NSCLC
- Verastem Q4 2025 Earnings Preview
- Verastem posts preliminary 2025 revenue, plans clinical updates in 2026
- Seeking Alpha’s Quant Rating on Verastem
Read the full article on Seeking Alpha
For further details see:
Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2
Verastem Inc.
NASDAQ: VSTM
VSTM Trading
-0.47% G/L:
$6.37 Last:
891,337 Volume:
$6.23 Open:
VSTM Latest News
VSTM Stock Data
$424,027,638
66,108,246
1.4%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Needham
